ICC 2022

Yong Teng, Speaker at Cancer Congress 2022
Keynote Presentation
Yong Teng, Emory University, United States

Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott-Aldrich syndrome protein family member, appears to play a major role not only in the regulation of act [....] » Read More

George Zachos, Speaker at  Cancer Congress
Keynote Presentation
George Zachos, University of Crete, Greece

Increasing evidence indicates that cancer metastasis is regulated by specific genetic pathways independent of those controlling tumorigenesis and cancer growth. WASF3, a Wiskott-Aldrich syndrome protein family member, appears to play a major role not only in the regulation of act [....] » Read More

Michael Thompson, Speaker at Cancer Congress
Keynote Presentation
Michael Thompson, University of Toronto, Canada

Will be Updated Soon...

Shinya Tajima, Speaker at Cancer Conferences 2022
Keynote Presentation
Shinya Tajima, National Hospital Organization Shizuoka Medical Center, Shizuoka, Japan

Breast papillary lesions exhibit broad range. Tajima et al. reported in discrimination between benign intraductal papilloma (IDP) and malignant endocrine ductal carcinoma in situ (E-DCIS), new marker of CD56 is useful for discriminating between benign and malignant. Hence, detect [....] » Read More

Veronica James, Speaker at Cancer Conferences
Keynote Presentation
Veronica James, Australian National University, Australia

Every cancer sends out a type-specific signal, as soon as it starts, thus providing the earliest possible diagnosis of the cancer by the cancer itself. These signals can be detected as specific alterations in the low angle X-ray diffraction patterns for skin and/or hair. In [....] » Read More

Atif A Ahmed, Speaker at Cancer Conferences 2022
Keynote Presentation
Atif A Ahmed, Children’s Mercy Hospitals and Clinics, United States

Will be Updated Soon...

Lei Chen, Speaker at Cancer Conference 2022
Oral Presentation
Lei Chen, Uppsala University, Sweden

The ability to observe, evaluate, and count even extremely rare nucleic acid sequence variants in biological samples is a frequent need in biology and medicine. In particular, rare tumor-specific mutations in patient samples serve as excellent markers to monitor the course of mal [....] » Read More

Lynleigh Evans, Speaker at Cancer Congress 2022
Oral Presentation
Lynleigh Evans, Western Sydney Local Health District, Australia

While multidisciplinary teams (MDTs) are now considered an essential part of cancer care decision-making, how they perform varies widely. The authors hypothesised that a comprehensive, multipronged improvement program, and associated annual member survey, could strengthen MDT per [....] » Read More

K M Yacob , Speaker at Cancer Congress 2022
Oral Presentation
K M Yacob , Marma Health Centre, India

How can we prove the fever is not a symptom.  The fever is not symptom when examined in various directions.   In fever, both symptoms of disease and symptoms of fever are included. Deduct symptom of disease from total symptoms, we will get symptoms of fever. we [....] » Read More

Dieudonne Molamba Moningo, Speaker at Cancer Conferences 2022
Oral Presentation
Dieudonne Molamba Moningo, University Clinics of Kinshasa, Congo

Objective: Prostate cancer (PCa) is hormone-dependent cancer. In our area, most patients often arrive at the locally advanced stage or the metastatic stage. This justifies the choice of androgen deprivation as the mode of treatment. The objective of this study was to describe the [....] » Read More

Christophe Grosset, Speaker at Cancer Conferences 2022
Oral Presentation
Christophe Grosset, University of Bordeaux, France

Background: Despite recent progress in the characterization of tumour components, the 3D organization of this pathological tissue and the parameters determining its internal architecture remain elusive.   Methods: We analysed the organization of hepatoblastoma patient- [....] » Read More

Alan Prem Kumar, Speaker at Cancer Conferences 2022
Oral Presentation
Alan Prem Kumar, National University of Singapore, Singapore

Breast cancer is a principal cause of death in women globally and a diverse malignancy. Despite recent advances in breast cancer therapeutics, mortality of highly metastatic triple negative breast cancer (TNBC) subtype remains high; due to their lack hormone receptors expression [....] » Read More

Alexander Plotnikov, Speaker at Cancer Congress 2022
Oral Presentation
Alexander Plotnikov, Weizmann Institute of Science, Israel

Colorectal cancer (CRC) is the third most commonly occurring cancer in men and the second most commonly occurring cancer in women. CRC incidence and number of deaths are rapidly growing over the World. Number of new cases jumped from 800,000 to 2,000,000 in the last 30 years. Pro [....] » Read More

Yana Yurevna Kiseleva, Speaker at Cancer Conferences 2022
Oral Presentation
Yana Yurevna Kiseleva, , Russian Scientific Center of Roentgenoradiology, Russian Federation

The adaptation of CAR-therapy for a treatment of solid malignant tumors is currently considered as a highly promising opportunity for future therapies. One of the approaches in primary human T cell engineering effective commonly used for CAR gene delivery is retroviral gene trans [....] » Read More

Nancy Gavert, Speaker at Cancer Conferences 2022
Oral Presentation
Nancy Gavert, Weizmann Institute of Science, Israel

Precision cancer therapy depends on correctly predicting each patient’s response to treatment according to the unique characteristics of their tumor. This may explain the difficulty in translation of pre-clinical studies to effective treatment protocols. Predicting the resp [....] » Read More

Muhammed Rauf Ahmed, Speaker at Cancer Conferences 2022
Poster Presentation
Muhammed Rauf Ahmed, Shaheed Zulfiqar Ali Bhutto Medical University, Pakistan

To observe the combined effect of platelet-rich plasma (PRP) and preconditioned adipose-derived mesenchymal stem cells (ADMSCs) on the injured articular cartilage of the rat. Materials & methods: Animals in the study received an intra-articular injection of PRP and precond [....] » Read More

Samuel Baek, Speaker at Cancer Conferences 2022
Poster Presentation
Samuel Baek, Department of Orthopaedic Surgery Seoul Red Cross Hospital, Korea, Republic of

This study examined whether there are seasonal variations in the number of osteosarcoma (OSA) and malignant bone tumors cases from the database of the Korean Health Insurance Review & Assessment Service and an internet search of the volume data related to OSA and whether ther [....] » Read More

Andrea Martisova, Speaker at Cancer Conferences 2022
Poster Presentation
Andrea Martisova, Masaryk University , Czech Republic

Epithelial to mesenchymal transition (EMT) is one of the key processes in tumour progression and metastasis development. TGF-β signaling plays an important role in this process, and through a cascade of signaling events, it enhances the transcription of EMT drivers. Recently [....] » Read More

Neema Tiwari, Speaker at Cancer Conferences 2022
Poster Presentation
Neema Tiwari, Swami Vivekanand Subharti University,Meerut, India

Polycythaemia vera (PV) belongs to the group of myeloproliferative neoplasms with excessive increase in hemoglobin levels. They are clinically characterized by nonspecific symptoms such as fatigability, pruritus, early satiety due to splenomegaly, increased risk of infections, an [....] » Read More

Joo Hee Yoon, Speaker at Oncology Conferences
Poster Presentation
Joo Hee Yoon, The Catholic University of Korea, Korea, Republic of

Abstract Objective: Evaluate the association between the clipping of distal external iliac lymph nodes and risk of postoperative lower extremity lymphedema in women who underwent radical hysterectomy and PLND with or without PALND for cervical cancer. Methods: Data from 128 p [....] » Read More

Rajender Singh Arora, Speaker at Cancer Congress 2022
Oral Presentation
Rajender Singh Arora, MGM medical college, India

Prospective study done at SSCH and ACF since 2012 on Oral squamous cell carcinoma (OSCC) and till date more than 400 cases have been enrolled , all the patients of early OSCC of tongue / buccal Mucosa / lower and upper alvelous / pallet / RMT etc. With cN0 nodes, SOND was done an [....] » Read More

Elham Fayyaz, Speaker at Cancer Conferences 2022
Oral Presentation
Elham Fayyaz, Shahid Beheshti University, Iran (Islamic Republic of)

In the pediatric psycho-oncology research literature, the inner world of primary childhood cancer caregivers at the beginning of treatment is a phenomenon that needs to be further recognized. This is when a parent becomes a caregiver; the period of a complete transition. The p [....] » Read More

Zohrehsadat Moosavi , Speaker at Cancer Conferences 2022
Oral Presentation
Zohrehsadat Moosavi , Islamic Azad University of Malard , Iran (Islamic Republic of)

Today, electrical waste in the developing countries of the Middle East, especially Iran, is undergoing a rapid growing trend, and unfortunately, there has been no proper management, awareness, information and training of citizens to persuasion for separation and management of suc [....] » Read More

 Mahmoud Alrahawy , Speaker at Cancer Conferences 2022
Oral Presentation
Mahmoud Alrahawy , East Suffolk and North Essex NHS Foundation Trust , United Kingdom

Aim: Locally advanced rectal cancer (LARC) is treated by neoadjuvant chemoradiotherapy (NCRT) followed by surgery after restaging with magnetic resonance imaging (MRI). Texture analysis (TA) is an imaging biomarker that could assess MRIs heterogeneity by measuring grey-level inte [....] » Read More

Prakash kinthada, Speaker at Cancer Conferences 2022
Oral Presentation
Prakash kinthada, NATIONAL INSTIYUTE OF MEDICAL SCIENCES(NIMS)UNVERSITY,JAIPUR, India

Cancer is a dreadful disease and any practical solution in combating this disease is of paramount importance to public health. Cancer patients have burdened by drug induced toxic side effects, and no turned to seek help from the complementary and alternative medicine hoping for [....] » Read More

Christine Akinyi Odinga, Speaker at Cancer Congress 2022
Oral Presentation
Christine Akinyi Odinga, Moi University, Kenya

Cancer, one of the world’s dreaded diseases continues to remain a myth to this day. It involves the potential uncontrolled growth of cells that usually divide and invade other body parts thereby interfering with their normal functions. There are tissue cancers and blood can [....] » Read More

Adeola Oluwakemi Olowofolahan, Speaker at Cancer Conferences 2022
Oral Presentation
Adeola Oluwakemi Olowofolahan, University of ibadan, Nigeria

 The incidence of uterine dysfunction (endometrial hyperplasia) is on the rise and the current treatment options (surgery, chemotherapy and radiotherapy) are associated with some side effects and costly. Natural products are now being explored for their therapeutic potential [....] » Read More

Shannon Hearney, Speaker at Cancer Congress 2022
Poster Presentation
Shannon Hearney, University of California Davis, United States

Pancreatic cancer is a notoriously costly and deadly form of cancer. Many types of treatment centers exist for patients to seek care from, including high volume centers which have shown promise to provide the highest quality of care. While it may be true that this type of center [....] » Read More

Demmouche Abbassia, Speaker at Cancer Conferences 2022
Poster Presentation
Demmouche Abbassia, Faculty of Natural Sciences and life-Djillali Liabes University, Algeria

Breast cancer is the most common female cancer, the same trend is seen in developed and developing countries.. The objective of our work is to research the risk factors of breast cancer in women in west of Algeria, and to trace the epidemiological, clinical, anatomo-histo-patholo [....] » Read More

Djoko Agung Priyambodo, Speaker at Cancer Conferences 2022
Poster Presentation
Djoko Agung Priyambodo, Sebelas maret university, surakarta, Indonesia

Introduction Inhalation of carbogen (95% oxygen / 5% carbon dioxide) and nicotinamide is said to improve intratumor oxygenation and improve post-therapy outcomes (radiotherapy and chemotherapy). This is evidenced in cancer patients who obtained improvements in gradient recalled e [....] » Read More

Alhumam Alkhusheh , Speaker at Cancer Conferences 2022
Poster Presentation
Alhumam Alkhusheh , University of Nottingham. , United Kingdom

Background: The proline rich homeodomain (PRH) protein is one of the few discovered proteins that cannot be classified exclusively as an oncogene or a tumour suppressor. It is proposed to have dual tumour suppressive and oncogenic action, dependent on location and condition. Both [....] » Read More

Abdullah Ali  Gaffer, Speaker at Cancer Conferences 2022
Poster Presentation
Abdullah Ali Gaffer, Ministry of Public Health, Yemen

  Background:    Identifying and understanding the factor  that influence health-related quality of life (HRQOL) in patients with leukemia  is critical to creating more appropriate clinical, counseling, and social support programs to develop treatmen [....] » Read More

Michail R Ponizovskiy, Speaker at Cancer Conferences 2022
Poster Presentation
Michail R Ponizovskiy, Kiev Regional p/n Hospital, Ukraine

Balance catabolic exoergonic and anabolic endoergonic processes, causing chemical potentials and electric charges on cellular membranes exerting cellular capacitors operation, is the mechanism maintenance stability Internal Energy [36,6°C by which all enzymes operate etc.] of [....] » Read More

Sama Rahimi Devin, Speaker at Cancer Congress 2022
Poster Presentation
Sama Rahimi Devin, College of Agriculture, Shiraz University, Iran (Islamic Republic of)

Milk thistle is a medicinal plant with anti-inflammatory, anti-oxidant properties and in the treatment of chronic liver diseases. The therapeutic properties of this plant have been showed within the treatment of Alzheimer's malady, Parkinson's illness, burns, osteoporosis [....] » Read More

Watsapp